← Leaderboards
Camilia R Martin
Children'S Hospital Boston
$5,838,145
Attributed
$8,354,576
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,354,576 · 8
By mechanism
R01$7,810,022 · 3
R21$484,326 · 1
M01$60,228 · 4
Top collaborators
- Sarah N Taylor9 shared
Others in their field
Top investigators on “Postnatal”
- Leonardo Trasande · New York University School Of Medicine$79,321,500
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$39,079,074
- Nenad Sestan · Yale University$36,892,570
- Mary A Staat · Children'S Hospital Med Ctr (Cincinnati)$36,362,169
- Robert O Wright · Brigham And Women'S Hospital$30,687,606
Research focus
PostnatalNutritionalNutritionGrowthPremature InfantNeonatal Intensive Care UnitsNeonatalInfantBirthFuturePublic HealthPremature BirthPreventionLeadFatty AcidsPathway InteractionsResponseMetabolismNutrientPregnancyFetalLifeBiologicalBrain
Grant awards (21)
Metabolic mechanisms induced by enteral DHA and ARA supplementation in preterm infants$713,326
R01 · FY2025 · HD · contact PI
Phenotypic Driven Growth Trajectories in Very Preterm Infants to Define Nutritionally Mediated Health Outcomes and Modifiable Targets$424,605
R01 · FY2025 · HD
CMV+ milk: morbidity risk & translational potential of neutralizing antibodies$215,063
R21 · FY2025 · HD · contact PI
Metabolic mechanisms induced by enteral DHA and ARA supplementation in preterm infants$707,830
R01 · FY2024 · HD · contact PI
Phenotypic Driven Growth Trajectories in Very Preterm Infants to Define Nutritionally Mediated Health Outcomes and Modifiable Targets$420,603
R01 · FY2024 · HD
CMV+ milk: morbidity risk & translational potential of neutralizing antibodies$269,263
R21 · FY2024 · HD · contact PI
Metabolic mechanisms induced by enteral DHA and ARA supplementation in preterm infants$712,937
R01 · FY2023 · HD · contact PI
Phenotypic Driven Growth Trajectories in Very Preterm Infants to Define Nutritionally Mediated Health Outcomes and Modifiable Targets$424,780
R01 · FY2023 · HD
Metabolic mechanisms induced by enteral DHA and ARA supplementation in preterm infants$768,338
R01 · FY2022 · HD · contact PI
Phenotypic Driven Growth Trajectories in Very Preterm Infants to Define Nutritionally Mediated Health Outcomes and Modifiable Targets$424,711
R01 · FY2022 · HD
Phenotypic Driven Growth Trajectories in Very Preterm Infants to Define Nutritionally Mediated Health Outcomes and Modifiable Targets$435,732
R01 · FY2021 · HD
Impact of fatty acid imbalance in intestinal health and disease in prematurity$739,878
R01 · FY2017 · DK · contact PI
Impact of fatty acid imbalance in intestinal health and disease in prematurity$771,198
R01 · FY2016 · DK · contact PI
Impact of fatty acid imbalance in intestinal health and disease in prematurity$766,368
R01 · FY2015 · DK · contact PI
Impact of fatty acid imbalance in intestinal health and disease in prematurity$499,716
R01 · FY2014 · DK · contact PI
INHALED NO FOR THE PREVENTION AND TX OF CHRONIC LUNG DISEASE IN PRETERM INFNT$8,683
M01 · FY2007 · RR · contact PI
INHALED NO FOR THE PREVENTION AND TX OF CHRONIC LUNG DISEASE IN PRETERM INFNT$19,201
M01 · FY2006 · RR · contact PI
INHALED NO FOR THE PREVENTION AND TX OF CHRONIC LUNG DISEASE IN PRETERM INFNT$14,526
M01 · FY2005 · RR
LONGITUDINAL STUDY OF EARLY CHILDHOOD EDUCATION$2,179
M01 · FY2005 · RR
Longitudinal Study of Early Childhood Education$12,846
M01 · FY2004 · RR
Inhaled N.O. for the Prevention and Tx. of Chronic Lung Disease in Preterm Infnt$2,793
M01 · FY2004 · RR